NOMURA HOLDINGS INC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
NOMURA HOLDINGS INC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2021$207,000
-94.0%
12,691
-91.0%
0.00%
-83.3%
Q4 2020$3,463,000
+828.4%
140,300
+1458.9%
0.01%
+500.0%
Q3 2020$373,000
-56.7%
9,000
-50.0%
0.00%
-66.7%
Q2 2020$862,000
-82.6%
18,000
-55.0%
0.00%
-83.3%
Q4 2019$4,957,000
+151.0%
40,000
+33.3%
0.02%
+157.1%
Q3 2019$1,975,000
-24.3%
30,000
-77.4%
0.01%
+16.7%
Q2 2019$2,610,000
+736.5%
133,000
+4650.0%
0.01%
+500.0%
Q1 2019$312,000
+15500.0%
2,800
+17400.0%
0.00%
Q4 2018$2,000
-99.2%
16
-99.1%
0.00%
-100.0%
Q3 2018$236,000
-35.5%
1,865
-38.3%
0.00%0.0%
Q2 2017$366,000
-4.7%
3,023
+11.8%
0.00%0.0%
Q2 2016$384,000
-96.8%
2,704
-94.6%
0.00%
-96.9%
Q3 2014$11,955,000
+18.8%
50,216
+20.3%
0.03%
+966.7%
Q2 2014$10,064,000
+3084.8%
41,739
+4275.2%
0.00%
Q1 2014$316,000
-91.3%
954
-98.2%
0.00%
-100.0%
Q4 2013$3,632,000
+359.2%
53,202
+198.4%
0.02%
+183.3%
Q2 2013$791,000
+95.3%
17,832
+65.3%
0.01%
+50.0%
Q1 2013$405,000
-25.8%
10,790
-32.6%
0.00%
-33.3%
Q4 2012$546,00016,0000.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders